Baxter Healthcare Corporation is recalling 523,896 bags of Levofloxacin (levofloxacin) Injection in 5% Dextrose (5 mg/mL) because the medication was found to be superpotent. This means the concentration of the antibiotic is higher than specified, which could result in patients receiving a higher dose of the drug than intended. The recall affects 50 mL, 100 mL, and 150 mL bags distributed across the United States and Puerto Rico. Consumers should contact their healthcare provider or pharmacist for guidance and return any unused product to the pharmacy for a refund.
A superpotent drug contains a higher concentration of the active ingredient than prescribed, which can lead to an accidental overdose or an increased risk of adverse side effects associated with levofloxacin. While the risk level is categorized as low, receiving an incorrect dosage of prescription medication can cause serious health complications.
Healthcare facilities and consumers can return the product for a refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.